0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query current partnering congestive heart failure partnering 2009 2014.Your search for "" gave back 1052096 results.
Ventricular Tachycardia - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Summary The global Heart Implants market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment,...
Catalog:
HYR
January 2022
Price: USD 1,800.00
The global Pacemaker Implantation market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a...
Catalog:
GIR
October 2023
Price: USD 3,480.00
Summary Publisher estimates that the Congestive Heart Failure (CHF) Treatment Devices market size will grow from xxx Million USD in 2020 to xxxx...
Catalog:
HYR
May 2021
Price: USD 2,000.00
Summary The Congestive Heart Failure (CHF) Treatment Devices market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with...
Catalog:
HYR
February 2021
Price: USD 2,000.00
Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021 Summary Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021 provides...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
Chronic Heart Failure (Cardiovascular) - Drugs in Development, 2021 Summary Chronic Heart Failure (Cardiovascular) - Drugs in Development, 2021...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
Diastolic Heart Failure (Cardiovascular) - Drugs in Development, 2021 Summary Diastolic Heart Failure (Cardiovascular) - Drugs in Development, 2021...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
Systolic Heart Failure (Cardiovascular) - Drugs in Development, 2021 Summary Systolic Heart Failure (Cardiovascular) - Drugs in Development, 2021...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
Acute Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Acute Heart Failure Drugs in Development...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,000.00
Chronic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Chronic Heart Failure Drugs in...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,000.00
Systolic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Systolic Heart Failure Drugs in...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,000.00
Diastolic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Diastolic Heart Failure Drugs in...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,000.00
Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294...
Catalog:
Global Markets Direct
February 2018
Price: USD 3,500.00
Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) Drugs in Development by Therapy Areas and...
Catalog:
Global Markets Direct
June 2022
Price: USD 3,500.00
